GlaxoSmithKline gearing up for Alli launch

Share this article:

GlaxoSmithKline continues to prepare for the rollout of its new OTC diet pill Alli.

The UK drugmaker is scheduled to begin shipping Alli to US pharmacies today, with the weight loss remedy expected to officially go on sale next Monday.

Early demand from retailers has been strong from retailers, including Wal-Mart Stores, and 400,000 Alli starter kits are being shipped to fill the supply chain.

Analysts estimate the launch of Alli will be one of the biggest ever for an OTC medicine. GlaxoSmithKline is spending an estimated $150 million on marketing in the US.

Alli will retail for between $55 and $60 for a month’s supply, based on a regimen of three pills a day.

Citigroup estimates global Alli sales could hit $724 million by 2011.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.